SLU-PP-332, 5-Amino-1MQ and BPC-157 tablets: research profile

Last updated Oct 8, 2026

Identity

Name

SLU-PP-332, 5-Amino-1MQ and BPC-157 tablets

Taken from the supplier's public product page. No certificate of analysis is on file, and a research-record profile has not been compiled for this listing.

A research-record profile has not been compiled for this listing. The lines above are the supplier's product name only.

Regulatory status

• FDA (compounding): Not reviewed for this listing. FDA source ↗
• Products referenced on this site are sold for laboratory research use only, not for human or veterinary consumption. This summary isn't legal or regulatory advice.

Lab-tested SLU-PP-332, 5-Amino-1MQ and BPC-157 tablets lots (0)

No certificate of analysis for a SLU-PP-332, 5-Amino-1MQ and BPC-157 tablets product has been published by either of our suppliers (checked Oct 8, 2026), so there are no lot pages yet. Paramount Peptides lists SLU-PP-332 (500mcg) / 5-Amino-1MQ (50mg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 90 Tablets; see where SLU-PP-332, 5-Amino-1MQ and BPC-157 tablets is listed for what its product page says.

Where SLU-PP-332, 5-Amino-1MQ and BPC-157 tablets is listed →